The Centre for Health Protection (CHP) in Hong Kong announced on Saturday that the city has recorded a total of 30 mpox cases throughout 2024. Of these, 23 were identified as local transmissions, while seven were classified as imported cases. The most recent report involved a 29-year-old man.

Data indicates a significant uptick in infections during the latter half of the year, with 21 of the 30 total cases occurring since August. This surge represents 70 percent of the year’s total infection count. In response to these figures, health officials are actively urging members of high-risk groups—specifically those who engage in high-risk sexual contact—to prioritize protective measures. The CHP is emphasizing the importance of vaccination as a primary tool to reduce the risk of infection and curb further spread within the community.

While the report provides a clear breakdown of the case numbers and the demographic focus of the health advisory, it does not detail the specific clinical severity of the cases or provide comparative data regarding regional infection trends outside of Hong Kong. The focus remains strictly on the local public health response and the call for increased vaccination uptake among the identified high-risk populations.